Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Adelaide, South Australia-based Seonix Bio operates in Biotechnology Research. It is privately held, and its site is seonixbio.com. It holds two addresses on record across two office countries. Headcount on record is 16. Its latest round on record is Series unknown, US$748.2K. It is listed alongside six similar brands, mostly in Medical Device.
Seonix Bio's mission is to improve the treatment and prevention of blinding eye disease, through the development of advanced risk prediction tools.
| Countries | 2 |
|---|---|
| Primary country | AU |
All codes: AU US
| Rounds | 3 |
|---|---|
| Axis | 2025 to 2027 |
| Series unknown · 30 Aug 2025 | US$ 748.2K |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
16 counted staff profiles at January 2026, above the self-reported 2–10 band.
Two addresses on record across 2 countries. Primary: Adelaide, South Australia.
Three rounds. Latest 30 August 2025: Series unknown, US$748,200, investor Business.gov.au.
11 profiles list Seonix Bio as a peer — 84th percentile in Biotechnology Research. It lists ten peers of its own. ICSION and Xynoptik list it back.